tirzepatide approval obesity F.D.A. Approves New Drug That Will Compete With Wegovy BMI Guidelines for Tirzepatide Eligibility

Can GLP-1 Cookbooks Help With Long-Term Maintenance

Malaga, Spain

Nature Reviews Endocrinology , 17(7), 391-405

In 2024, the combined sales of tirzepatide's diabetes and weight-loss formulations reached $16.46 billion , representing approximately 36% of Eli Lilly's total revenue

Always remember to consult your healthcare provider for personalized advice and to monitor your hydration status regularly

It's easy for a patient to associate increased sun sensitivity with Mounjaro because it's the newest or most impactful drug in their regimen, when the actual UV risk stems from an older, long-standing prescription like a blood pressure pill or another diabetes medication